Intron Life Sciences Private Limited

Produces animal feeds, including poultry, aquaculture, ruminant, and probiotic strains, since 2018.

2018 | Prakasam, Andhra Pradesh (India) | Active
Last Updated: November 16, 2024

Intron Life Sciences Profile

Key Indicators

  • Authorised Capital ₹ 12.80 Cr
  • Paid Up Capital ₹ 10.32 Cr
  • Company Age 6 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 23.80 Cr
  • Satisfied Charges ₹ 22.00 Cr
  • Revenue Growth 25.00%
  • Profit Growth -10.99%
  • Ebitda 35.85%
  • Net Worth -16.34%
  • Total Assets 8.46%

About Intron Life Sciences

Intron Life Sciences Private Limited (ILSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 28 September 2018 (Six years and four months 27 days old ). Its registered office is in Prakasam, Andhra Pradesh, India.

The Company is engaged in the Life Sciences Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.80 Cr and a paid-up capital of Rs 10.32 Cr.

The company currently has active open charges totaling ₹23.80 Cr. The company has closed loans amounting to ₹22.00 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Intron Life Sciences Private Limited India is Ronak Modi as COMPANY SECRETARY. Sreemannarayana Pasumarthi, Pavan Velpuri, and Nithyagovind serve as directors at the Company.

Company Details

Corporate Identity Details

  • CIN/LLPIN

    U24299AP2018PTC109365

  • Company No.

    109365

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    28 Sep 2018

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Vijayawada

Industry

Life Sciences

Who are the key members and board of directors at Intron Life Sciences?

Executive Team (2)

NameDesignationAppointment DateStatus
Sreemannarayana Pasumarthi Country flag representing In Managing Director28-Sep-2018Current
Ronak Modi Company Secretary02-Nov-2022Current

Board Members (2)

NameDesignationAppointment DateStatus
Pavan Velpuri Country flag representing In Whole-Time Director 28-Sep-2018Current
Nithyagovind Country flag representing In Director 04-Dec-2018Current

Financial Performance of Intron Life Sciences.

Intron Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25% increase. The company also saw a substantial fall in profitability, with a 10.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.34%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
25.00%
Revenue from Operations
25.42%
Total Assets
8.46%
Profit or Loss
-10.99%
Net Worth
-16.34%
EBITDA
35.85%

What is the Ownership and Shareholding Structure of Intron Life Sciences?

In 2023, Intron Life Sciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹23.80 Cr

Satisfied Charges

₹22.00 Cr

Charges Breakdown by Lending Institutions

  • Axis Bank Limited : 22.30 Cr
  • Hdfc Bank Limited : 1.50 Cr

Latest Charge Details

DateLenderAmountStatus
15 Nov 2023Hdfc Bank Limited₹2.09 MOpen
09 Feb 2023Hdfc Bank Limited₹6.10 MOpen
13 Jan 2023Axis Bank Limited₹22.30 CrOpen
25 Apr 2022Hdfc Bank Limited₹6.83 MOpen
24 Dec 2021Others₹17.00 CrSatisfied

How Many Employees Work at Intron Life Sciences?

Intron Life Sciences has a workforce of 160 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Intron Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intron Life Sciences's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Intron Life Sciences

Recent activity within the organization

  • Annual General Meeting

    Intron Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Charges

    A charge with Axis Bank Limited of Rs. 22.30 Cr registered on 13 Jan 2023 with Charge ID 100681962 was modified on 09 Aug 2024.

    09 Aug 2024

  • Balance Sheet

    Intron Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.

    31 Mar 2024

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.21 Cr with Charge ID 100816777 was registered on 15 Nov 2023.

    15 Nov 2023

  • Charges

    A charge registered on 24 Dec 2021 via Charge ID 100513886 with Others was fully satisfied on 01 Mar 2023.

    01 Mar 2023

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.61 Cr with Charge ID 100707301 was registered on 09 Feb 2023.

    09 Feb 2023

Recent News, Updates & Announcement

Frequently asked questions

  • Intron Life Sciences Private Limited was incorporated on 28 Sep 2018.

  • The authorized share capital of Intron Life Sciences Private Limited is ₹ 12.80 Cr and paid-up capital is ₹ 10.32 Cr.

  • Currently 4 directors are associated with Intron Life Sciences Private Limited.

    • Sreemannarayana Murali Krishna Pasumarthi
    • Pavan Kumar Velpuri
    • Ronak Modi
    • Nithyagovind
  • As per Ministry of Corporate Affairs (Mca), the registered address of Intron Life Sciences Private Limited is Plot No.368 375 Apiic Industrial Growth Centre, India, Gundlapalli, Andhra Pradesh, 523211.

  • The corporate identification number (CIN) of Intron Life Sciences Private Limited is U24299AP2018PTC109365 and the company number is 109365 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Intron Life Sciences Private Limited is https://www.intronlifesciences.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for Intron Life Sciences Private Limited has risen by 25.00%.

  • As Per 2023 financial reports, 160 employees are currently employed by Intron Life Sciences Private Limited.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Intron Life Sciences Private Limited has experienced an downturn of -16.34%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Intron Life Sciences Private Limited amount to ₹ 23.80 Cr.

  • The most recent Balance Sheet for Intron Life Sciences Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Biotechnology